Expressing support for the recognition of "Hidradenitis Suppurativa Awareness Week".

H. Res. 484 is a resolution introduced in the House of Representatives by Mrs. Dingell in the 119th Congress. It expresses support for recognizing “Hidradenitis Suppurativa Awareness Week” and designates the first week of June for this purpose. The resolution outlines a set of policy goals related to HS—emphasizing public awareness, improved diagnosis, investment in biomedical research, expanded access to therapies, and addressing disparities in care. It provides context about HS, including its prevalence (about 3.3 million people in the U.S.), the painful and chronic nature of the disease, high burden on quality of life, and the significant issue of misdiagnosis and delayed diagnosis. It also notes that only a small number of FDA-approved biologic therapies exist as of June 1, 2025, underscoring the need for further research and better treatment options. Overall, the resolution is symbolic and aspirational, aiming to mobilize awareness and guide policy discussions without creating new mandatory programs or funding by itself.